tirzepatide compunded Compounded GLP-1/GIP Program Compounded Tirzepatide for Weight Loss:

While the medication itself does not require tapering from a pharmacological standpoint, the clinical context surrounding discontinuationparticularly the management of underlying conditions like diabetes or obesitydemands careful planning and medical supervision to ensure patient safety and optimize long-term health outcomes

They create a biological window of opportunity

The pattern typically aligns with peak gastrointestinal side effects , particularly nausea and fatigue

So if the hair loss does not ease off after 6 to 12 months but instead takes on a clear pattern (a receding hairline, a thinning crown), an unmasked predisposition may be behind it

Always provide accurate medical information during your consultation so the prescribing clinician can make the safest decision for you